The cervical cancer vaccine still makes sense at age 44. The cervical cancer vaccine is usually available to women before or at the age of 45. The vaccine reduces the risk of HPV infection and thus reduces the chance of developing cervical cancer. 44-year-old women are also at risk of developing cervical cancer, so it is still relevant to take the cervical cancer vaccine. The cervical cancer vaccine consists of three types of vaccines: bivalent vaccine, quadrivalent vaccine, and nine-valent vaccine, and the appropriate age for vaccination is 9-45 years old, and the earlier the age of vaccination, the better the effect. It should be noted that those who have hypersensitivity to the active ingredients of the vaccine or any of the excipient ingredients are prohibited from receiving HPV vaccine, and those who have symptoms of hypersensitivity after injection of this product should not receive this product again. Regular cervical cancer screening is still required after HPV vaccination.